Pyrizinamide

Pyrizinamide

Product Name : Pyrizinamide

Grade : IP / BP / USP

Therapeutic Category : Antitubercular

CAS No : 98-96-4

COA : Available

MSDS : Available

Description

Pyrazinamide is a medication used to treat tuberculosis. For active tuberculosis it is often used together with rifampin, isoniazid, and either streptomycin or ethambutol. It is taken by mouth.

Pyrazinamide is only used in combination with other drugs such as isoniazid and rifampicin in the treatment of Mycobacterium tuberculosis. It is never used on its own.

Common side effects include nausea, loss of appetite, muscle pains, and rash. More serious side effects include gout, liver toxicity, and sensitivity to sunlight. It is unclear if use during pregnancy is safe but it is likely okay during breastfeeding. Pyrazinamide is in the antimycobacterial class of medications.

    Packaging details

    Packaging details: 25kg/drum with double plastic bags inside; packed in a cardboard drum or fiber HDPE drum.

    Storage: Stored in a clean, cool, dry area; keep away from moisture and strong, direct light/heat.

    Shelf Life: 5 years if sealed and store away from direct sun light.

    Additional Information

    The most widely recognized markets for this item incorporate the accompanying nations. If you don’t mind ask with us if your nation or district isn’t recorded:

    ASIA: Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Afghanistan, Israel, Jordan, Pakistan, Russia, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, and so forth..

    AFRICA: South Africa, Uganda, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, and so forth.

    NORTH & SOUTH AMERICA: Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela, USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Brazil, Bahamas, Ecuador, and so forth .

    EUROPE: France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Austria, Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, and so forth.

    OCEANIA: Fiji, Australia, New Zealand, and so forth.